AT397344B - Verfahren zur herstellung eines oralen therapeutischen systems für carbamazepin - Google Patents

Verfahren zur herstellung eines oralen therapeutischen systems für carbamazepin Download PDF

Info

Publication number
AT397344B
AT397344B AT0199387A AT199387A AT397344B AT 397344 B AT397344 B AT 397344B AT 0199387 A AT0199387 A AT 0199387A AT 199387 A AT199387 A AT 199387A AT 397344 B AT397344 B AT 397344B
Authority
AT
Austria
Prior art keywords
cellulose
core
therapeutic system
carbamazepine
water
Prior art date
Application number
AT0199387A
Other languages
German (de)
English (en)
Other versions
ATA199387A (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ATA199387A publication Critical patent/ATA199387A/de
Application granted granted Critical
Publication of AT397344B publication Critical patent/AT397344B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT0199387A 1986-08-07 1987-08-06 Verfahren zur herstellung eines oralen therapeutischen systems für carbamazepin AT397344B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.

Publications (2)

Publication Number Publication Date
ATA199387A ATA199387A (de) 1993-08-15
AT397344B true AT397344B (de) 1994-03-25

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0199387A AT397344B (de) 1986-08-07 1987-08-06 Verfahren zur herstellung eines oralen therapeutischen systems für carbamazepin

Country Status (30)

Country Link
US (1) US4857336A (fr)
JP (1) JP2592460B2 (fr)
KR (1) KR950006219B1 (fr)
AT (1) AT397344B (fr)
AU (1) AU597403B2 (fr)
BE (1) BE1000235A3 (fr)
CA (1) CA1302267C (fr)
CH (1) CH668187A5 (fr)
DD (1) DD285718A5 (fr)
DE (1) DE3725824C2 (fr)
DK (1) DK175497B1 (fr)
ES (1) ES2007100A6 (fr)
FI (1) FI86143C (fr)
FR (1) FR2602425B1 (fr)
GB (1) GB2193632B (fr)
GR (1) GR871234B (fr)
HK (1) HK33793A (fr)
HU (1) HU206978B (fr)
IE (1) IE59718B1 (fr)
IL (1) IL83386A (fr)
IT (1) IT1215618B (fr)
LU (1) LU86966A1 (fr)
MY (1) MY100767A (fr)
NL (1) NL194780C (fr)
NO (1) NO173726C (fr)
NZ (1) NZ221347A (fr)
PH (1) PH25090A (fr)
PT (1) PT85489B (fr)
SE (1) SE502590C2 (fr)
ZA (1) ZA875804B (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3868077D1 (de) * 1987-01-14 1992-03-12 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
AU657114B2 (en) * 1991-01-16 1995-03-02 Fmc Corporation Carrier for active agents, and solid dosage forms prepared therewith
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
DK1017392T3 (da) 1997-09-25 2002-10-21 Bayer Ag Lægemiddel
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
AU746339B2 (en) * 1998-04-29 2002-04-18 Arius Two, Inc. Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
WO2002055009A1 (fr) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Systeme de liberation espacee de medicaments
IN190699B (fr) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
US20040156900A1 (en) * 2001-04-10 2004-08-12 Shanghvi Dilip Shantilal Time pulsed release composition
RU2189225C1 (ru) * 2001-09-14 2002-09-20 Нестерук Владимир Викторович Лекарственное средство на основе карбамазепина
TW200302748A (en) * 2002-02-01 2003-08-16 Pfizer Prod Inc Osmotic delivery system
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
WO2003075830A2 (fr) * 2002-03-14 2003-09-18 Sun Pharmaceutical Industries Limited Système de délivrance contrôlée de médicament par voie orale
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
RU2240798C1 (ru) * 2003-06-25 2004-11-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая противосудорожным и психотропным действием, и способ ее получения
EP1690540A1 (fr) * 2005-02-15 2006-08-16 Neuro3D Composition comprenant l'ocapéridone
EP1877040A1 (fr) * 2005-04-25 2008-01-16 Teva Pharmaceuticals USA, Inc. Preparations a liberation prolongee
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
SI2054031T1 (sl) 2006-07-21 2016-09-30 Biodelivery Sciences International, Inc. Transmukozne naprave za administracijo z izboljšanim vnosom
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
EP2240162A4 (fr) 2007-12-06 2013-10-09 Bend Res Inc Nanoparticules comprenant un polymère non ionisable et un copolymère de méthacrylate fonctionnalisé par amine
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
SG10201610097WA (en) 2011-08-18 2017-01-27 Biodelivery Sciences Int Inc Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050589A1 (fr) * 1980-10-17 1982-04-28 Ciba-Geigy Ag Compositions pharmaceutiques à effet anti-épileptique et anti-névralgique ainsi que leur préparation
US4409212A (en) * 1981-04-16 1983-10-11 Ciba-Geigy Corporation Method of preventing and treating cerebral insufficiency
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050589A1 (fr) * 1980-10-17 1982-04-28 Ciba-Geigy Ag Compositions pharmaceutiques à effet anti-épileptique et anti-névralgique ainsi que leur préparation
US4409212A (en) * 1981-04-16 1983-10-11 Ciba-Geigy Corporation Method of preventing and treating cerebral insufficiency
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
H. KALA, U. HAACK, F. FAHR, P. POLLANDT, PHARMAZIE 41 (JÄNNER 1986), HEFT 1, SEITEN 61 BIS 62 *

Also Published As

Publication number Publication date
MY100767A (en) 1991-02-14
FI86143B (fi) 1992-04-15
IT8748270A0 (it) 1987-08-05
FI873409A0 (fi) 1987-08-05
NO173726C (no) 1994-01-26
KR950006219B1 (ko) 1995-06-12
JP2592460B2 (ja) 1997-03-19
FR2602425B1 (fr) 1990-09-14
NO873298L (no) 1988-02-08
NZ221347A (en) 1989-12-21
IT1215618B (it) 1990-02-22
GB2193632B (en) 1990-04-25
SE502590C2 (sv) 1995-11-20
DE3725824C2 (de) 1998-12-17
GR871234B (en) 1987-12-08
AU597403B2 (en) 1990-05-31
HUT44930A (en) 1988-05-30
ES2007100A6 (es) 1989-06-01
LU86966A1 (fr) 1989-03-08
NL194780B (nl) 2002-11-01
DK410787D0 (da) 1987-08-06
KR880002511A (ko) 1988-05-09
NL8701857A (nl) 1988-03-01
SE8703034D0 (sv) 1987-08-03
HU206978B (en) 1993-03-01
IL83386A (en) 1992-01-15
ATA199387A (de) 1993-08-15
ZA875804B (en) 1988-02-08
FI86143C (fi) 1992-07-27
SE8703034L (sv) 1988-02-08
DD285718A5 (de) 1991-01-03
JPS6344525A (ja) 1988-02-25
IE872110L (en) 1988-02-07
DK175497B1 (da) 2004-11-15
PT85489A (en) 1987-09-01
NO873298D0 (no) 1987-08-06
PH25090A (en) 1991-02-19
US4857336A (en) 1989-08-15
AU7661787A (en) 1988-02-11
IE59718B1 (en) 1994-03-23
FI873409A7 (fi) 1988-02-08
GB2193632A (en) 1988-02-17
NO173726B (no) 1993-10-18
CA1302267C (fr) 1992-06-02
DK410787A (da) 1988-02-08
DE3725824A1 (de) 1988-02-11
HK33793A (en) 1993-04-16
FR2602425A1 (fr) 1988-02-12
GB8717643D0 (en) 1987-09-03
CH668187A5 (de) 1988-12-15
BE1000235A3 (fr) 1988-09-20
PT85489B (pt) 1990-06-29
NL194780C (nl) 2003-03-04
IL83386A0 (en) 1987-12-31

Similar Documents

Publication Publication Date Title
AT397344B (de) Verfahren zur herstellung eines oralen therapeutischen systems für carbamazepin
EP0277092B1 (fr) Système thérapeutique pour médicaments peu solubles
EP0339506B1 (fr) Système osmotique oral avec adhésion améliorée de la membrane au noyau
EP1024793B1 (fr) Systeme osmotique de liberation de medicament
DE60038698T2 (de) Hydrogel-gesteuerte dosierungsform
DE69738089T2 (de) Feste orale Dosierungsformen enthaltend Valsartan
DE19681389B3 (de) Dosierungsform, umfassend Oxybutynin
DE3407873C2 (fr)
DE69805001T2 (de) Osmotische darreichungsform mit zwei mantelschichten
DE69229949T2 (de) Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe
EP0720473B1 (fr) Pellets de budesonide a liberation controlee et leur procede de preparation
DE69629797T2 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
AT398165B (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung
DE69212710T2 (de) Pharmazeutische Zusammensetzung mit kontrollierter Freigabe und bioadhäsiven Eigenschaften
DE69720055T2 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
DE69720995T2 (de) Granulate für die vorbereitung von schnellzerfallende und schnelllösendezubereitungen mit hohem anteil an wirkstoff
DE69427466T2 (de) Bisacodyl dosierungsform
DE69709101T2 (de) Therapie mittels gleichförmiger arzneistoffverabreichung
DD248057A5 (de) Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-/imino/2-(2-methoxyethoxy)ethyliden/-oxy/-9s)-erythromycin und verfahren zu ihrer herstellung
DE60019334T2 (de) Antivirale arznei
CH665124A5 (de) Verfahren zur herstellung von tabletten mit regulierter wirkstoffabgabe.
EP2155172A2 (fr) Système de rétention gastrique renfermant un corps d'alginate
DE3909520A1 (de) Feste, schnell zerfallende darreichungsformen
WO2005009329A2 (fr) Medicament a base de 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol caracterise par une liberation differee du principe actif
DE69414863T2 (de) Behälter, der ein hydrophober arzneimittel enthält

Legal Events

Date Code Title Description
ELA Expired due to lapse of time